Jennison Associates’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $516K | Sell |
29,010
-3,169
| -10% | -$56.4K | ﹤0.01% | 540 |
|
2025
Q1 | $573K | Buy |
+32,179
| New | +$573K | ﹤0.01% | 539 |
|
2020
Q2 | – | Sell |
-13,201
| Closed | -$889K | – | 676 |
|
2020
Q1 | $889K | Sell |
13,201
-179
| -1% | -$12.1K | ﹤0.01% | 501 |
|
2019
Q4 | $1.13M | Sell |
13,380
-2,754
| -17% | -$232K | ﹤0.01% | 511 |
|
2019
Q3 | $1.21M | Buy |
16,134
+102
| +0.6% | +$7.63K | ﹤0.01% | 523 |
|
2019
Q2 | $1.01M | Buy |
16,032
+1,940
| +14% | +$123K | ﹤0.01% | 555 |
|
2019
Q1 | $679K | Buy |
+14,092
| New | +$679K | ﹤0.01% | 587 |
|